0001209191-16-111756.txt : 20160401
0001209191-16-111756.hdr.sgml : 20160401
20160401172238
ACCESSION NUMBER: 0001209191-16-111756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160330
FILED AS OF DATE: 20160401
DATE AS OF CHANGE: 20160401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PARROTT DRIVE
CITY: SHELTON
STATE: CT
ZIP: 06484
BUSINESS PHONE: 203-567-1500
MAIL ADDRESS:
STREET 1: ONE PARROTT DRIVE
CITY: SHELTON
STATE: CT
ZIP: 06484
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menzaghi Frederique Ph.D.
CENTRAL INDEX KEY: 0001597152
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 161548211
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 1 PARROTT DRIVE
CITY: SHELTON
STATE: CT
ZIP: 06484
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-30
0
0001346830
Cara Therapeutics, Inc.
CARA
0001597152
Menzaghi Frederique Ph.D.
C/O CARA THERAPEUTICS, INC.
1 PARROTT DRIVE
SHELTON
CT
06484
0
1
0
0
VP-Research & Development
Employee Stock Option (Right to Buy)
6.00
2016-03-30
4
A
0
65000
0.00
A
2026-03-30
Common Stock
65000
65000
D
The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 30, 2016, in each case subject to the Reporting Person's Continuous service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
/s/Darren DeStefano, Attorney-in-Fact
2016-04-01